semaglutide health canada Yesterday, approved generic semaglutide, making Canada the first G7 country to do so. Cost has kept evidence-based obesity treatment out of reach for many Canadians. Some people pay out of Health Canada's market authorisation for

Remember to opt for an oil-free composition when buying ceramide products

To determine whether BAL fluid redox measures reflected intracellular (HAEC) levels, overlapping samples were compared ( n = 26)

New NCQA HEDIS data shows consistent, year-over-year gains in chronic kidney disease (CKD) testing among people with diabetes across every major payor segment from 2021 to 2024: Commercial HMO: +5.6 pts 49.5% Commercial PPO: +3.3 pts 42.9% Medicaid HMO: +4.2 pts 37.7% Medicare HMO: +8.7 pts 52.9% Medicare PPO: +9.1 pts 49.4% The result

We're really starting to dramatically improve outcomes for people with diabetes and kidney disease

For details, see the update in the Multivitamin Supplements Review

If cagrilintide is approved, it would likely be priced in a similar range to other premium injectable weight-loss medicationsthough the exact number could go in either direction depending on insurance negotiations, patient assistance programs, and competitive dynamics with Zepbound and other competing medications